VIA
ORGO icon

Virtus Investment Advisers’s Organogenesis Holdings ORGO Stock Holding History

Virtus Investment Advisers’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-49,000
Closed -$157K – 627
2024
Q4 		$157K Buy
+49,000
New +$164K 0.12% 220
2024
Q1 		– Sell
-21,500
Closed -$87.9K – 373
2023
Q4 		$87.9K Hold
21,500
– – 0.07% 248
2023
Q3 		$68.4K Buy
+21,500
New +$68.3K 0.05% 237

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtus Investment Advisers's ORGO Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Organogenesis Holdings (ORGO) in Q1 2025, closing a stake of 49,000 shares — an estimated $157K sold.

Virtus Investment Advisers first reported a position in ORGO in Q3 2023 and held it in 3 quarters. The position peaked at $157K in Q4 2024. 136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Organogenesis Holdings position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 49,000 Organogenesis Holdings shares in Q1 2025, an estimated $157K.
  • Virtus Investment Advisers first reported a position in Organogenesis Holdings in Q3 2023 and held it in 3 quarters.
  • Virtus Investment Advisers's Organogenesis Holdings position peaked at $157K in Q4 2024.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.